- Home
- MDBH vs GRCE Comparison
MDBH vs GRCE Comparison
Compare MDBH & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- GRCE
- Stock Information
- Founded
- MDBH 1997
- GRCE 2002
- Country
- MDBH United States
- GRCE United States
- Employees
- MDBH N/A
- GRCE N/A
- Industry
- MDBH
- GRCE
- Sector
- MDBH
- GRCE
- Exchange
- MDBH Nasdaq
- GRCE NYSE
- Market Cap
- MDBH 40.5M
- GRCE 42.4M
- IPO Year
- MDBH 2023
- GRCE N/A
- Fundamental
- Price
- MDBH $4.44
- GRCE $3.08
- Analyst Decision
- MDBH
- GRCE Strong Buy
- Analyst Count
- MDBH 0
- GRCE 1
- Target Price
- MDBH N/A
- GRCE $12.00
- AVG Volume (30 Days)
- MDBH 3.5K
- GRCE 62.2K
- Earning Date
- MDBH 08-12-2025
- GRCE 08-15-2025
- Dividend Yield
- MDBH N/A
- GRCE N/A
- EPS Growth
- MDBH N/A
- GRCE N/A
- EPS
- MDBH 0.84
- GRCE N/A
- Revenue
- MDBH $3,574,131.00
- GRCE N/A
- Revenue This Year
- MDBH N/A
- GRCE N/A
- Revenue Next Year
- MDBH N/A
- GRCE N/A
- P/E Ratio
- MDBH $5.27
- GRCE N/A
- Revenue Growth
- MDBH N/A
- GRCE N/A
- 52 Week Low
- MDBH $3.61
- GRCE $1.75
- 52 Week High
- MDBH $12.00
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- MDBH 50.35
- GRCE N/A
- Support Level
- MDBH $3.91
- GRCE N/A
- Resistance Level
- MDBH $4.71
- GRCE N/A
- Average True Range (ATR)
- MDBH 0.23
- GRCE 0.00
- MACD
- MDBH -0.05
- GRCE 0.00
- Stochastic Oscillator
- MDBH 49.53
- GRCE 0.00
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.